Droia Ventures
Venture capital
RollingLast verified 9 Nov 2026
Droia Ventures is a life sciences venture capital firm that invests globally in early-stage therapeutics companies focused on oncology and genetic diseases.
1 deal in the last 24 months, latest 5 Nov 2026. Derived from its deals in the news.
Key facts
- Stages
- Series A
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Belgium
- Timing
- Rolling applications
- Focus
- oncology therapeutics; genetic disease therapeutics; novel drug development platforms
- How to apply
- Apply route unknown
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Anaheim Bio · Netherlands | Series A | Biotech & pharma, Healthtech | €40M | – | 5 Nov 2026 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients.
https://droiaventures.com/ - Sectors
We are specialists, investing exclusively in therapeutics for oncology and genetic disease.
https://droiaventures.com/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Droia Ventures? Claim this profile to confirm what you invest in.